AVXL
Anavex Life Sciences Corp
NASDAQ: AVXL · HEALTHCARE · BIOTECHNOLOGY
$3.34
+2.45% today
Updated 2026-04-30
Market cap
$309.52M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.46
Dividend yield
—
52W range
$3 – $14
Volume
1.4M
Anavex Life Sciences Corp (AVXL) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-685000.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | +100.0% | — | — | — | — | — |
| Cost of revenue | $750.00 | $70000.00 | $75000.00 | $410.00 | $12810.00 | $63110.00 | — | $12000.00 | $0.00 | $0.00 | $1252.00 | $0.00 | $0.00 | — | — | — | — | — | — | — |
| Gross profit | $-750.00 | $-70000.00 | $-75000.00 | — | $-12810.00 | $-63110.00 | — | $-12000.00 | $0.00 | $0.00 | $-1252.00 | $0.00 | $0.00 | — | — | — | — | — | — | — |
| Gross margin | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.0% | — | — | — | — | — | — |
| R&D | — | $959698.00 | $1.48M | $2.14M | $2.73M | $2.60M | $2.65M | $263847.00 | $732395.00 | $2.27M | $7.25M | $10.67M | $13.34M | $22.26M | $25.23M | $32.98M | $37.92M | $43.72M | $41.84M | $37.59M |
| SG&A | $25476.00 | $618224.00 | $3.79M | $2.59M | $2.91M | $3.44M | $1.55M | $1.87M | $2.24M | $4.84M | $8.33M | $5.01M | $5.99M | $6.85M | $5.86M | $9.02M | $13.07M | $12.04M | $11.04M | $13.82M |
| Operating income | $-25591.00 | $-1.58M | $-5.27M | $-4.73M | $-5.65M | $-6.18M | $-4.32M | $-2.13M | $-2.97M | $-7.11M | $-15.59M | $-15.54M | $-19.18M | $-28.75M | $-31.09M | $-42.00M | $-50.99M | $-47.50M | $-52.88M | $-51.41M |
| Operating margin | — | — | — | — | — | — | — | — | — | — | — | — | — | 4197.4% | — | — | — | — | — | — |
| EBITDA | $-25650.00 | $-1.58M | $-5.26M | $-4.03M | $-2.79M | $-5.14M | $-471797.00 | $-2.14M | $-11.59M | $-12.11M | $-15.04M | $-15.57M | $-19.13M | $-28.88M | $-31.06M | $-37.64M | $-47.62M | $-47.50M | $-43.00M | $-46.38M |
| EBITDA margin | — | — | — | — | — | — | — | — | — | — | — | — | — | 4216.3% | — | — | — | — | — | — |
| EBIT | $-25591.00 | $-1.58M | $-5.26M | $-4.03M | $-2.79M | $-5.14M | $-473655.00 | $-2.14M | $-11.59M | $-12.11M | $-15.04M | $-15.57M | $-36.64M | $-55.52M | $-57.78M | $-74.83M | $-47.62M | $-47.50M | $-45.29M | — |
| Interest expense | $115.00 | $3308.00 | $11474.00 | $57861.00 | $291826.00 | $90246.00 | $144304.00 | $51341.00 | $7089.00 | $71825.00 | $11.32M | $0.00 | $30943.00 | $151133.00 | $4.81M | $4.04M | $946988.00 | $964000.00 | $0.00 | $0.00 |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-25532.00 | $-1.58M | $-5.35M | $-5.50M | $-8.78M | $-7.31M | $-8.30M | $-3.70M | $-11.37M | $-12.11M | $-14.74M | $-13.46M | $-17.45M | $-26.29M | $-26.28M | $-37.91M | $-47.98M | $-47.49M | $-43.00M | $-46.38M |
| Net income growth (YoY) | — | -6088.3% | -238.7% | -2.8% | -59.7% | +16.8% | -13.6% | +55.4% | -207.2% | -6.5% | -21.7% | +8.7% | -29.7% | -50.7% | +0.1% | -44.2% | -26.6% | +1.0% | +9.5% | -7.8% |
| Profit margin | — | — | — | — | — | — | — | — | — | — | — | — | — | 3838.7% | — | — | — | — | — | — |